CN102070502B - 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 - Google Patents
一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 Download PDFInfo
- Publication number
- CN102070502B CN102070502B CN201110003499.8A CN201110003499A CN102070502B CN 102070502 B CN102070502 B CN 102070502B CN 201110003499 A CN201110003499 A CN 201110003499A CN 102070502 B CN102070502 B CN 102070502B
- Authority
- CN
- China
- Prior art keywords
- thick product
- reaction
- recrystallization
- oxo
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000006243 chemical reaction Methods 0.000 claims abstract description 62
- IHLAQQPQKRMGSS-BYPYZUCNSA-N 2-[(4s)-4-hydroxy-2-oxopyrrolidin-1-yl]acetamide Chemical compound NC(=O)CN1C[C@@H](O)CC1=O IHLAQQPQKRMGSS-BYPYZUCNSA-N 0.000 claims abstract description 36
- 238000001953 recrystallisation Methods 0.000 claims abstract description 36
- 238000002360 preparation method Methods 0.000 claims abstract description 22
- WKNMKGVLOWGGOU-UHFFFAOYSA-N 2-aminoacetamide;hydron;chloride Chemical compound Cl.NCC(N)=O WKNMKGVLOWGGOU-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 19
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 85
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 78
- 239000000243 solution Substances 0.000 claims description 46
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 38
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 38
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 38
- 235000019441 ethanol Nutrition 0.000 claims description 33
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 26
- 230000002378 acidificating effect Effects 0.000 claims description 24
- 239000003513 alkali Substances 0.000 claims description 24
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 21
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 20
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 20
- 238000006386 neutralization reaction Methods 0.000 claims description 20
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 17
- 235000010755 mineral Nutrition 0.000 claims description 17
- 239000011707 mineral Substances 0.000 claims description 17
- 239000003957 anion exchange resin Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 14
- 239000003729 cation exchange resin Substances 0.000 claims description 13
- 238000010792 warming Methods 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 125000002091 cationic group Chemical group 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 11
- 239000011347 resin Substances 0.000 claims description 11
- 229920005989 resin Polymers 0.000 claims description 11
- 150000003440 styrenes Chemical class 0.000 claims description 11
- 239000012046 mixed solvent Substances 0.000 claims description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 10
- 235000017550 sodium carbonate Nutrition 0.000 claims description 10
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 10
- -1 alcohol compound Chemical class 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 239000013078 crystal Substances 0.000 claims description 7
- 238000002425 crystallisation Methods 0.000 claims description 7
- 238000007689 inspection Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 235000015320 potassium carbonate Nutrition 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 11
- 239000003456 ion exchange resin Substances 0.000 abstract description 5
- 229920003303 ion-exchange polymer Polymers 0.000 abstract description 5
- 238000000746 purification Methods 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 239000012043 crude product Substances 0.000 abstract 2
- 229920000070 poly-3-hydroxybutyrate Polymers 0.000 abstract 2
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 abstract 1
- 150000007529 inorganic bases Chemical class 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 230000000630 rising effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 26
- 229960001227 oxiracetam Drugs 0.000 description 10
- IHLAQQPQKRMGSS-UHFFFAOYSA-N oxiracetam Chemical compound NC(=O)CN1CC(O)CC1=O IHLAQQPQKRMGSS-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 4
- IHLAQQPQKRMGSS-SCSAIBSYSA-N 2-[(4r)-4-hydroxy-2-oxopyrrolidin-1-yl]acetamide Chemical compound NC(=O)CN1C[C@H](O)CC1=O IHLAQQPQKRMGSS-SCSAIBSYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002664 nootropic agent Substances 0.000 description 1
- 230000001777 nootropic effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical class OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
实施例4 | 实施例5 | 实施例6 | 实施例7 | |
无机碱 | 碳酸钠 | 碳酸氢钠 | 碳酸钾 | 碳酸钾 |
实施例4 | 实施例5 | 实施例6 | 实施例7 | |
溶剂 | 甲醇 | 丙醇 | 丁醇 | 异丙醇 |
(S)-4-卤-3-羟基丁酸酯 | |
实施例4 | (S)-4-氯-3-羟基丁酸甲酯 |
实施例5 | (S)-4-氯-3-羟基丁酸乙酯 |
实施例6 | (S)-4-溴-3-羟基丁酸甲酯 |
实施例7 | (S)-4-溴-3-羟基丁酸乙酯 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110003499.8A CN102070502B (zh) | 2008-10-13 | 2008-10-13 | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110003499.8A CN102070502B (zh) | 2008-10-13 | 2008-10-13 | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810232861 Division CN101367757B (zh) | 2008-10-13 | 2008-10-13 | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102070502A CN102070502A (zh) | 2011-05-25 |
CN102070502B true CN102070502B (zh) | 2012-07-25 |
Family
ID=44029283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110003499.8A Expired - Fee Related CN102070502B (zh) | 2008-10-13 | 2008-10-13 | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102070502B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0223328A1 (en) * | 1985-07-26 | 1987-05-27 | Denki Kagaku Kogyo Kabushiki Kaisha | Process for producing oxiracetam |
US5276164A (en) * | 1990-06-26 | 1994-01-04 | Lonza Ltd. | Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide |
CN1956953A (zh) * | 2004-05-25 | 2007-05-02 | 安国药品株式会社 | 旋光纯4-羟基-2-氧化-1-吡咯烷乙酰胺的制备方法 |
-
2008
- 2008-10-13 CN CN201110003499.8A patent/CN102070502B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0223328A1 (en) * | 1985-07-26 | 1987-05-27 | Denki Kagaku Kogyo Kabushiki Kaisha | Process for producing oxiracetam |
US5276164A (en) * | 1990-06-26 | 1994-01-04 | Lonza Ltd. | Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide |
CN1956953A (zh) * | 2004-05-25 | 2007-05-02 | 安国药品株式会社 | 旋光纯4-羟基-2-氧化-1-吡咯烷乙酰胺的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102070502A (zh) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101367757B (zh) | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 | |
CN102603607A (zh) | (r)-奥拉西坦的制备方法 | |
CN103664561B (zh) | 一种叶菌唑及其中间体的制备方法 | |
CN102531989B (zh) | 一种(s)-奥拉西坦的纯化方法 | |
CN102060744B (zh) | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 | |
CN102659702B (zh) | 一种1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的纯化方法 | |
CN102070502B (zh) | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 | |
CN102690222A (zh) | 一种(r,s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 | |
CN102603603B (zh) | 一种制备(s)-奥拉西坦的方法 | |
CN102531988A (zh) | 一种左旋奥拉西坦的纯化方法 | |
CN102702051B (zh) | 一种西司他丁钠的制备方法 | |
CN102603597A (zh) | (s)-奥拉西坦的制备方法 | |
CN103373958B (zh) | 5-乙基吡啶-2,3-二甲酸二乙酯的制备方法 | |
CN102603594A (zh) | (s)-奥拉西坦的制备方法 | |
CN102603596A (zh) | (s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 | |
CN106349145A (zh) | 一种制备促智药物(s)‑奥拉西坦的方法 | |
CN103553949B (zh) | 一种α-氨基-对羟基苯乙酸甲酯或其硫酸盐的制备方法 | |
CN106349144A (zh) | 一种(s)‑奥拉西坦中间体的制备方法 | |
CN102628075B (zh) | 一种青霉素酰化酶拆分生产手性氨基酸的方法及其产品 | |
CN103724249B (zh) | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 | |
CN102603600A (zh) | 一种制备(s)-奥拉西坦的方法 | |
CN102603605A (zh) | (s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 | |
CN104072407A (zh) | 一种Rho激酶抑制剂Y27632化合物的制备方法 | |
SU1479460A1 (ru) | Способ получени селективного к бору сорбента | |
CN102603599B (zh) | 一种制备(s)-奥拉西坦的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: CHONGQING RUNZE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: CHONGQING RUNZE MEDICAL INSTRUMENTS LTD. |
|
CP03 | Change of name, title or address |
Address after: 400042 Chongqing city Yubei District Qinye Road No. 9 Patentee after: CHONGQING RUNZE PHARMACEUTICAL Co.,Ltd. Address before: 401120 Chongqing city Yubei District Shuangfeng Bridge Street Airport Road No. 296 Building 1 yuan and 7 2- store Patentee before: CHONGQING RUNZE MEDICAL INSTRUMENTS Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: CHONGQING DONGZE PHARMACEUTICAL TECHNOLOGY DEVELOP Free format text: FORMER OWNER: CHONGQING RUNZE PHARMACEUTICAL CO., LTD. Effective date: 20140305 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 400042 YUBEI, CHONGQING TO: 400030 SHAPINGBA, CHONGQING |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140305 Address after: 400030 Chongqing city Shapingba District Yubei Road No. 50 of No. 13-15-6A Patentee after: DONGZE PHARMACEUTICAL SCIENCE AND TECHNOLOGY Co.,Ltd. Address before: 400042 Chongqing city Yubei District Qinye Road No. 9 Patentee before: CHONGQING RUNZE PHARMACEUTICAL Co.,Ltd. |
|
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Ye Lei Inventor before: Chen Yuying Inventor before: Ping Yuan Inventor before: Yu Yuanyuan Inventor before: Ye Lei Inventor before: Rong Zuyuan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN YUYING PING YUAN YU YUANYUAN YE LEI RONG ZUYUAN TO: YE LEI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170823 Address after: 400042 Chongqing city Yubei District Qinye Road No. 9 Patentee after: CHONGQING RUNZE PHARMACEUTICAL Co.,Ltd. Address before: 400030 Chongqing city Shapingba District Yubei Road No. 50 of No. 13-15-6A Patentee before: DONGZE PHARMACEUTICAL SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 Termination date: 20211013 |
|
CF01 | Termination of patent right due to non-payment of annual fee |